Pinnacle Financial Group, Inc.’s Inovio Pharmaceuticals INO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$48 Buy
+39
New +$44 ﹤0.01% 2238

Other funds holding INO

Pinnacle Financial Group, Inc.'s INO Position: Q3 2026 in Review

Pinnacle Financial Group, Inc. opened a new position in Inovio Pharmaceuticals (INO) in Q3 2026: 39 shares worth $48. The stake represents ﹤0.01% of the portfolio and ranks #2238 among its holdings.

111 funds tracked by Wall St. Rank hold INO as of Q3 2026.

  • Pinnacle Financial Group, Inc. held 39 shares of Inovio Pharmaceuticals worth $48 as of Q3 2026.
  • Inovio Pharmaceuticals was a new Pinnacle Financial Group, Inc. position in Q3 2026.
  • Inovio Pharmaceuticals made up ﹤0.01% of Pinnacle Financial Group, Inc.'s portfolio in Q3 2026, its #2238 holding.
  • 111 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2026.

Based on Pinnacle Financial Group, Inc.'s 13F filing for Q3 2026, filed 16 Nov 2026.